LHRH-receptors and LHRH-agonist treatment in ovarian cancer: An overview
- 20 December 1990
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6), 1003-1006
- https://doi.org/10.1016/0960-0760(90)90457-v
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparison of Different Agonists and Antagonists of Luteinizing Hormone-Releasing Hormone for Receptor-Binding Ability to Rat Pituitary and Human Breast Cancer Membranes*Endocrinology, 1989
- Reproductive factors and risk of ovarian cancer: A prospective studyInternational Journal of Cancer, 1988
- Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: A preliminary reportCancer Letters, 1988
- LHRH agonists and human breast cancer cellsNature, 1987
- Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*Journal of Clinical Endocrinology & Metabolism, 1987
- Inhibitory effect of GnRH superagonist on the growth of human ovarian carcinoma NIH: OVCAR 3 in the nude mouseGynecologic Oncology, 1986
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Testosterone Secretion by Cultured Arrhenoblastoma Cells: Suppression by a Luteinizing Hormone-Releasing Hormone AgonistJournal of Clinical Endocrinology & Metabolism, 1982
- "INCESSANT OVULATION" AND OVARIAN CANCERThe Lancet, 1979
- INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?The Lancet, 1971